Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force
Davide Angioni, Julien Delrieu, Oskar Hansson, Howard M. Fillit, Paul S. S. Aisen, Jeffrey L. Cummings, John Randall Sims, Joel B. Braunstein, Marwan Noel Sabbagh, T. Bittner, Michael J. Pontecorvo, Sasha Bozeat, Jeffrey L. Dage, Emily A. Largent, Soeren Mattke, O. Correa, Laura Robledo, V. Baldivieso, Deanna R. Willis, Alireza Atri, Randall John Bateman, Pierre‐Jean Ousset, Bruno J. Vellas, Michael Walter Weiner
- ISSN / E-ISSN
- — / —
- DOI
- 10.14283/jpad.2022.85 ↗
- Volume · Issue · Pages
- 9 · 4 · 569-579
- Publisher
- Springer International Publishing AG
- Article URL
- https://doi.org/10.14283/jpad.2022.85 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Oct 2022
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Oct 2022 | OpenAlex |
Keywords (as given): Alzheimer's disease; blood biomarkers; clinical translation; early diagnosis; clinical trials; PET biomarkers; cerebrospinal fluid biomarkers; clinical implementation
HEC Status at Publication Not the journal's current status
HEC Status at PublicationConclusive
HEC status at publication
Recognized
X
Based on the recorded HEC dataset applicable to the article's publication date. Listed as X in the HEC list for 2022–23.
- Journal
- journal of prevention of Alzheimer's disease, The
- Publication date used
- 01 Oct 2022 (OpenAlex publication date)
- Applicable HEC period
- 2022–23 (version 2) · 01 Jul 2022 – 30 Jun 2023
- Category
- X
- Recognition status
- Recognized (OK_RECORD_FOUND)
- Source
- hjrs-2022-23 row 3431
- Verification status
- Verified against source · last verified 16 Oct 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.